MYBPC3 and cardiac hypertrophy: Wijnker et al. demonstrated that MyBPC3 mutations could affect oxidative stress and were associated with diastolic dysfunction, fibrosis, cardiac hypertrophy, and arrhythmias, which are all hallmarks of HCM (44).